| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |